The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
influenza virus vaccine
2 marketed package NDCs · 2 active manufacturers
What changed in the last 90 days
Every detected change for influenza virus vaccine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Flulaval 2026/2027Jul 29, 2026Mfr exitedID Biomedical Corporation of Quebec · influenza virus vaccine
- Fluarix 2026/2027Jul 29, 2026Mfr exitedGlaxoSmithKline Biologicals SA · influenza virus vaccine
- Fluarix 2026/2027Jul 22, 2026Mfr enteredGlaxoSmithKline Biologicals SA · influenza virus vaccine
- Flulaval 2026/2027Jul 22, 2026Mfr enteredID Biomedical Corporation of Quebec · influenza virus vaccine
Common questions
- Is Influenza virus vaccine in shortage right now?
- No. FDA does not currently list Influenza virus vaccine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Influenza virus vaccine?
- 2 companies have marketed Influenza virus vaccine in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.